Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/5022
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKarimov Mirvosit Mirvasikovich, Sobirova Guzal Naimovna, Zargarova Nargiza Rustamovna-
dc.date.accessioned2022-12-13T11:15:34Z-
dc.date.available2022-12-13T11:15:34Z-
dc.date.issued2022-
dc.identifier.issn978-0-578-26510-0-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/5022-
dc.description.abstractThe global and regional impact of the SARS-CoV-2 pandemic is of great concern. Although the availability of vaccines against SARS-CoV-2 has partially alleviated this concern in some parts of the world, it remains a global public health crisis. Diagnosing gut microbiota in patients after infection with COVID-19. The research was conducted on 120 (54 men and 66 women) patients aged 29 to 70 years and 20 healthy people treated for dysbacteriosis in the gastroenterology department of the Multidisciplinary Clinic of the Tashkent Medical Academy. The composition of intestinal microorganisms in patients with dysbacteriosis is almost the same, but its quantitative ratio differs according to whether or not they have had COVID-19.en_US
dc.language.isoen_USen_US
dc.publisherNorth American Academic Publishing Platformsen_US
dc.relation.ispartofseriesl 10.5281/zenodo.7219791;-
dc.subjectSARS-CoV-2, intestinal microbiota, methods, determineen_US
dc.titleMETHODS OF DETERMINING THE INTESTINAL MICROBIOTA IN PATIENTS AFTER COVID-19en_US
dc.title.alternativeArt of Medicine International Medical Scientific Journal 10.5281/zenodo.7219791en_US
dc.typeArticleen_US
Appears in Collections:Tashkent Medical Academy Historical Books

Files in This Item:
File Description SizeFormat 
5. Art of med_2022, 172-180.pdfThe global and regional impact of the SARS-CoV-2 pandemic is of great concern. Although the availability of vaccines against SARS-CoV-2 has partially alleviated this concern in some parts of the world, it remains a global public health crisis. Diagnosing gut microbiota in patients after infection with COVID-19. The research was conducted on 120 (54 men and 66 women) patients aged 29 to 70 years and 20 healthy people treated for dysbacteriosis in the gastroenterology department of the Multidisciplinary Clinic of the Tashkent Medical Academy. The composition of intestinal microorganisms in patients with dysbacteriosis is almost the same, but its quantitative ratio differs according to whether or not they have had COVID-19.427.96 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.